These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10512494)

  • 41. Effect of pioglitazone on dyslipidemia in hemodialysis patients with type 2 diabetes.
    Nakamura T; Ushiyama C; Osada S; Shimada N; Ebihara I; Koide H
    Ren Fail; 2001 Nov; 23(6):863-4. PubMed ID: 11777327
    [No Abstract]   [Full Text] [Related]  

  • 42. Unraveling the mechanism of action of thiazolidinediones.
    Kahn CR; Chen L; Cohen SE
    J Clin Invest; 2000 Dec; 106(11):1305-7. PubMed ID: 11104782
    [No Abstract]   [Full Text] [Related]  

  • 43. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 44. Rosiglitazone monotherapy and type 2 diabetes.
    Lawrence IG
    Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215
    [No Abstract]   [Full Text] [Related]  

  • 45. Thiazolidinediones for type 2 diabetes. No evidence exists that pioglitazone induces hepatic cytochrome P450 isoform CYP3A4.
    Glazer NB; Cheatham WW
    BMJ; 2001 Jan; 322(7280):235-6. PubMed ID: 11159615
    [No Abstract]   [Full Text] [Related]  

  • 46. FDA approves saxagliptin for type 2 diabetes.
    Traynor K
    Am J Health Syst Pharm; 2009 Sep; 66(17):1513. PubMed ID: 19710429
    [No Abstract]   [Full Text] [Related]  

  • 47. US FDA approves three new drugs for Type 2 diabetes.
    Bond T
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):101. PubMed ID: 23593719
    [No Abstract]   [Full Text] [Related]  

  • 48. New diabetes drug targets insulin resistance.
    Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
    [No Abstract]   [Full Text] [Related]  

  • 49. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
    Teter ML
    Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019
    [No Abstract]   [Full Text] [Related]  

  • 50. Guidance on rosiglitazone for type 2 diabetes mellitus.
    Matthews DR
    Lancet; 2001 Feb; 357(9254):481. PubMed ID: 11273100
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible vascular-protective effects of antidiabetic agents such as the thiazolidinediones (TZDs).
    Goldstein BJ
    Clin Ther; 2002 Aug; 24(8):1358-60; author reply 1360-2. PubMed ID: 12240785
    [No Abstract]   [Full Text] [Related]  

  • 52. New treatment for adult-onset diabetes.
    Zurlinden J
    Nurs Spectr (Wash D C); 1997 Aug; 7(16):8. PubMed ID: 9439332
    [No Abstract]   [Full Text] [Related]  

  • 53. Warner-Lambert voluntarily withdraws Rezulin.
    Diabetes Technol Ther; 2000; 2(2):290. PubMed ID: 11469273
    [No Abstract]   [Full Text] [Related]  

  • 54. [Insulin sensitizer. A new therapy option for type 2 diabetic patients].
    Filz HP
    MMW Fortschr Med; 2000 Sep; 142(38):31-3. PubMed ID: 11050888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Honing type 2 diabetes treatment.
    Blackburn G
    Health News; 2001 Jan; 7(1):1-2. PubMed ID: 11198405
    [No Abstract]   [Full Text] [Related]  

  • 56. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of a thiazolidinedione compound as a new antidiabetic drug].
    Toyota T
    Nihon Rinsho; 2001 Nov; 59(11):2211-8. PubMed ID: 11712410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
    Algenstaedt P; Hamann A
    Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
    [No Abstract]   [Full Text] [Related]  

  • 59. [Type 2 diabetes. A new kind of insulin sensitizer at the door].
    Böhm S
    MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588
    [No Abstract]   [Full Text] [Related]  

  • 60. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones].
    Lotz N
    MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.